HHS-OIG: Novartis Division, Sandoz, to Pay $12.6 Million in Civil Monetary Penalties for Misrepresenting Drug Pricing Data to Medicare Read more
OIG Soliciting Recommendations on New Safe Harbors To The Anti-Kickback Statute; Stakeholder Comments on Developing Special Fraud Alerts Read more
OIG Releases Annual “Top Management and Performance Challenges” Facing the Department of Health and Human Services Read more
Shire Pharmaceuticals Settles for $56.5 Million to Resolve False Claims Act Allegations Over ADHD Drugs Read more